Ringolsby: don’t bar the PED users from the Hall of Fame

6 Comments

Tracy Ringolsby makes a point that I find to be eminently reasonable:

There is a strong feeling among some that amphetamines actually enhance performances over a broader base than steroids. What it all underscores is that over time, athletes, in any sport, are always looking for ways to gain an edge on the competition. When one advantage becomes commonplace or is outlawed, the search intensifies for a newer and better aid.

With the advancements in science over time, the methods for gaining that edge have become more sophisticated, which makes it more difficult to detect the usage. As a result, in evaluating greatness of athletes — in baseball and other sports — it is always wiser to evaluate who were the elite of their era, and not try to draw firm statistical comparisons from one era to another because the conditions change so drastically.

That’s why to blindly eliminate anyone even suspected of using steroids from Hall of Fame consideration is inconsistent from previous evaluations.

Good point.  Of course, how one can overlook steroids yet still find Mark McGwire lacking is a bit curious, but maybe like me Ringolsby is a “discounter” when it comes to known PED users (i.e. we don’t bar them, but we grade them downward).

Oh, and John Franco gets Ringolsby’s vote. I can’t say I recall seeing him get any other support.  I’m not gonna go crazy about this. I don’t like it when unworthy candidates get bona fide campaigns behind them like Jack Morris is getting, but I think the random votes to random people like Franco are kinda fun.  I’m just waiting to see if Lenny Harris gets a vote.

Report: Yankees to promote Gleyber Torres

Yankees Torres Baseball
AP Images
3 Comments

Yankees top prospect Gleyber Torres will be promoted to the majors this weekend, per a report from Jack Curry of the YES Network. Torres was expected to make his debut earlier in the season, but his starting date was pushed back after he suffered a bout of back tightness last Monday. Now, however, it looks like he’s finally healthy enough to make an impact on a team that’s in sore need of an offensive boost. As of Saturday evening, the team has yet to officially confirm the move.

The 21-year-old infielder has made quite the impression in Triple-A Scranton/Wilkes-Barre this spring, slashing .370/.415/.543 with five extra-base hits and 11 RBI in his first 53 plate appearances. Prior to the start of the 2018 season, he was ranked first overall in the Yankees’ system and fifth among the league’s best prospects (via MLB Pipeline). His numbers at the plate have been made all the more impressive by the fact that he’s only 10 months removed from Tommy John surgery on his non-throwing arm; neither the injury nor the lengthy recovery process seems to have had any detrimental effect on his game play this year.

While Torres appears most comfortable as a shortstop, he’s not expected to supplant Didi Gregorius in a starting role. Instead, it’s more likely that he’ll sub in at second and third base among the likes of Miguel Andujar, Neil Walker and Ronald Torreyes.